Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
RLMD · NASDAQ · Pharmaceutical Preparations
Relmada Therapeutics (RLMD) · oqro.io/stocks/RLMD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$4.21+0.05 (+1.20%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a reduced position in RLMD for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed an increased position in RLMD for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a new position in RLMD for Q4 2025SourceInsider trade · Traded Aug 27, 2025 · Filed Aug 28, 2025
CEO purchased ~$87K of RLMD shares in the open marketSourceInsider trade · Traded Aug 26, 2025 · Filed Aug 28, 2025
CEO purchased ~$50K of RLMD shares in the open marketSourceInsider trade · Traded Aug 28, 2025 · Filed Aug 28, 2025
CEO purchased ~$41K of RLMD shares in the open marketSourceInsider trade · Traded May 20, 2025 · Filed May 20, 2025
CEO purchased ~$82K of RLMD shares in the open marketSourceInsider trade · Traded May 16, 2025 · Filed May 20, 2025
CEO purchased ~$77K of RLMD shares in the open marketSourceInsider trade · Traded May 19, 2025 · Filed May 20, 2025
CFO purchased ~$44K of RLMD shares in the open marketSourceInsider trade · Traded May 16, 2025 · Filed May 20, 2025
Director purchased ~$86K of RLMD shares in the open marketSourcePolitician trade (House) · Transaction Dec 12, 2022 · Disclosed Jan 20, 2023
Disclosed sale of RLMD — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Nov 8, 2022 · Disclosed Dec 12, 2022
Disclosed purchase of RLMD — reported range $1,001 - $15,000SourceInsider trade · Traded May 16, 2025 · Filed May 20, 2025
Officer purchased ~$103K of RLMD shares in the open marketSourceInsider trade · Traded May 20, 2025 · Filed May 20, 2025
CFO purchased ~$31K of RLMD shares in the open marketSourceInsider trade · Traded May 16, 2025 · Filed May 20, 2025
CFO purchased ~$22K of RLMD shares in the open marketSourceInsider trade · Traded May 19, 2025 · Filed May 20, 2025
CEO purchased ~$15K of RLMD shares in the open marketSource